TRAW - Traws Pharma, Inc.

1.9
-0.060   -3.158%

Share volume: 44,173
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$1.96
-0.06
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
18%
Profitability 0%
Dept financing 50%
Liquidity 50%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.84%
1 Month
-30.91%
3 Months
-76.46%
6 Months
-60.42%
1 Year
142.35%
2 Year
-88.59%
Key data
Stock price
$1.90
P/E Ratio 
0.00
DAY RANGE
$1.81 - $1.93
EPS 
-$5.11
52 WEEK RANGE
$0.24 - $19.44
52 WEEK CHANGE
$146.08
MARKET CAP 
5.952 M
YIELD 
N/A
SHARES OUTSTANDING 
25.311 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$46,370
AVERAGE 30 VOLUME 
$41,751
Company detail
CEO: Steven M. Fruchtman
Region: US
Website: www.trawspharma.com
Employees: 17
IPO year: 2013
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Recent news
loading